The poster presents Indonesia’s HPV vaccination program, highlighting its effectiveness, scale-up costs, and policy recommendations. It outlines the use of literature reviews, stakeholder engagement, and benchmarking with other countries to inform technical guidelines, emphasizing optimal scheduling, eligible age groups, and booster evaluation. Cost analyses compare procurement options across vaccine types (bivalent, quadrivalent, nonavalent) and supply mechanisms, including government and GAVI/UNICEF procurement. Data on infection prevalence and vaccine efficacy inform recommendations for nationwide school-based immunization targeting fifth-grade and 11-year-old girls. The study underscores the importance of efficient financial planning and multi-sectoral collaboration to ensure program sustainability and broader cervical cancer prevention.